SCHEMBL7109637

SCHEMBL7109637

CC(=O)c1cccc(CN2CCN(c3cccc(C(F)(F)F)n3)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.52
DRD2 P14416 3/20 0.50
DRD3 P35462 3/20 0.50
OPRM1 P35372 1/20 0.50
ACKR3 P25106 8/20 0.46
DRD4 P21917 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PTPN2 P17706 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8723295 0.89 HTR1A (0.52) HTR1ADRD2DRD3OPRM1ACKR3
SCHEMBL7184572 0.83 ALDH1A1 (0.62) HTR1ADRD2DRD3OPRM1ALDH1A1
SCHEMBL7183141 0.82 ALDH1A1 (0.57) HTR1ADRD2DRD3OPRM1DRD4
SCHEMBL6858059 0.82 KDM4E (0.59) HTR1ADRD2DRD3OPRM1DRD4
SCHEMBL6863207 0.81 DRD2 (0.54) HTR1ADRD2DRD3OPRM1DRD4
SCHEMBL6858056 0.78 ALDH1A1 (0.54) ALDH1A1L3MBTL1
SCHEMBL6863604 0.78 DRD2 (0.53) HTR1ADRD2DRD3OPRM1ALDH1A1
SCHEMBL7043039 0.78 KDM4E (0.67) HTR1AALDH1A1
SCHEMBL7043288 0.75 DRD4 (0.60) DRD2DRD3DRD4HTR2AHTR2C
SCHEMBL27981489 0.75 HRH3 (0.56) HTR1ADRD2DRD3OPRM1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817489-A BACTERICIDES, OR CHEMICAL INTERMEDIATES THEREOF; DRUG LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-10-06 US claimed
US-6800444-B1 USEFUL AS ANTIBACTERIAL AND OTHER PHARMACEUTICAL AGENTS/INTERMEDIATES ISIS PHARMACEUTICALS, INC. 2004-10-05 US disclosed
US-6660466-B1 Reacting reactive appendage compounds such as meta benzylic compounds or alpha-amide compounds with scaffold molecules having reactive functionalities and contacting the intermediate library with a reducing agent ISIS PHARMACEUTICALS, INC. 2003-12-09 US disclosed
US-6150129-A USEFUL AS ANTIBACTERIAL AND OTHER PHARMACEUTICAL AGENTS AND AS INTERMEDIATES FOR PREPARATION OF OTHER PHARMACEUTICAL AGENTS ISIS PHARMACEUTICALS, INC. (US) 2000-11-21 US disclosed
US-5922872-A BACTERICIDES AND DRUGS ISIS PHARMACEUTICALS, INC. (US) 1999-07-13 US disclosed
US-5817489-A BACTERICIDES, OR CHEMICAL INTERMEDIATES THEREOF; DRUG LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-10-06 US disclosed
US-5798360-A ANTIBACTERIAL AGENTS ISIS PHARMACEUTICALS, INC. (US) 1998-08-25 US disclosed
US-5780241-A ALTERING ELECTROCHEMICAL PROPERTIES BY DECYCLIZATION ISIS PHARMACEUTICALS, INC. (US) 1998-07-14 US disclosed
US-5731438-A BACTERICIDES; DRUGS ISIS PHARMACEUTICALS, INC. (US) 1998-03-24 US disclosed
WO-1998005332-A1 NOVEL HETEROCYCLE COMPOSITIONS ISIS PHARMACEUTICALS, INC. (US) 1998-02-12 WO disclosed